Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)

NAD+: Bloodwork Guide

Recommended lab tests and biomarkers to monitor before, during, and after NAD+ therapy. Testing schedules are based on clinical protocols and published monitoring guidelines.

Back to NAD+ overview

Before Starting (3 tests)

Biomarker Expected Effect Retest
Liver Enzymes → normalizes Once (baseline)
ALT/AST → normalizes Once (baseline)
Fasting Glucose → normalizes Once (baseline)

During Treatment (3 tests)

Biomarker Expected Effect Retest
NAD+ Levels ↑ increases Every 4 weeks
hs-CRP ↓ decreases Every 8 weeks
HOMA-IR → normalizes Every 12 weeks